SVWA
REGN icon

Sound View Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Sound View Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$873K Buy
2,127
+85
+4% +$35K 0.27% 95
2018
Q4 		$763K Buy
+2,042
New +$747K 0.28% 101

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sound View Wealth Advisors's REGN Position: Q1 2019 in Review

Sound View Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 4.2% in Q1 2019, buying an estimated $35K and bringing the position to 2,127 shares worth $873K. The position accounts for 0.27% of the portfolio, ranked #95.

Sound View Wealth Advisors first reported a position in REGN in Q4 2018 and has held it in 2 quarters since. 718 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • Sound View Wealth Advisors held 2,127 shares of Regeneron Pharmaceuticals worth $873K as of Q1 2019.
  • Sound View Wealth Advisors bought 85 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $35K.
  • Regeneron Pharmaceuticals made up 0.27% of Sound View Wealth Advisors's portfolio in Q1 2019, its #95 holding.
  • Sound View Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
  • 718 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Sound View Wealth Advisors's 13F filing for Q1 2019, filed 9 May 2019.